Charles Theuer

Dr. Charles P.
Theuer is a Chief Medical Officer at Halozyme Therapeutics, Inc., an Independent Director at Oncternal Therapeutics, Inc. and an Independent Director at 4D Molecular Therapeutics, Inc. He is on the Board of Directors at Oncternal Therapeutics, Inc. and 4D Molecular Therapeutics, Inc. Dr. Theuer was previously employed as a President, Chief Executive Officer & Director by TRACON Pharmaceuticals, Inc., a Chief Medical Officer & VP-Clinical Development by TargeGen, Inc., a Director-Clinical Oncology by Pfizer Inc., a Principal by National Cancer Institute, and an Assistant Professor-Surgical Oncology by University of California, Irvine.
He received his undergraduate degree from Massachusetts Institute of Technology, a doctorate degree from the University of California, Irvine and a doctorate degree from The University of California, San Francisco.